Operator
Good day, and thank you for standing by. Welcome to the CENTOGENE first-year 2020 earning results conference call. [Operator instructions] After the speaker s presentation, there would be a question-and-answer session. [Operator instructions] Please be advised that today s conference is being recorded.
[Operator instructions] I would now like to hand the conference over to your speaker today, Lennart Streibel. Please go ahead.
Lennart Streibel
Investor Relations
Thanks, Sarah. Hello and welcome. Thank you for joining us to discuss our Q4 and full-year 2020 results which were issued earlier today. You can view this presentation and the related press release on CENTOGENE s website.
REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy s 24th Annual Meeting
News provided by
Share this article
Share this article
ROCKVILLE, Md., April 27, 2021 /PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced that four oral and nine poster presentations will be presented at the American Society of Gene and Cell Therapy s 24
th Annual Meeting taking place from May 11 to 14, 2021, in virtual format. Presentations and posters will be available at https://www.asgct.org/.
Oral presentations include:
Abstract Title: Effects of Sexual Dimorphism and Genetic Background on AAV Tissue Transduction in Mice Following Intravenous Administration of a Diverse Capsid Pool (abstract #94)
Takeda launches mobile application to support patient for treatment of genetic diseases By siliconindia | Friday, 26 February 2021, 12:16 Hrs Takeda India, part of the Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, launched the XPERT EASE application. The application is developed for the exclusive use of healthcare professionals to address awareness-related challenges and enable an efficient digital ecosystem for disease updates and dose calculation for improved management of patients with rare lysosomal storage disorders Doctors screening, diagnosis, and treatment of genetic diseases have often been identified as challenging, including advising the dosage of medicines specific to patients individual needs. The XPERT EASE is designed to keep in mind such challenges while managing lysosomal storage disorders.
Takeda launches mobile application to support patient for treatment of genetic diseases prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.